• gaucher disease drugs market forecast points higher toward 2035, driven by gene therapy advances IndexBox Sat, 13 Jun 2026 07:06:18 GMT
• AMAN IPO News - SPAC Amanat Acquisition prices $75 million IPO, led by experienced biotech execs renaissancecapital.com Tue, 19 May 2026 07:00:00 GMT
• ASGCT President Terry Flotte Touts Rare Disease Initiatives as His Term Ends Genetic Engineering and Biotechnology News Wed, 13 May 2026 07:00:00 GMT
• gm1 gangliosidosis treatment market to reach usd 626.86 million openPR.com Tue, 12 May 2026 07:00:00 GMT
• sio gene therapies inc. (siox) eps diluted (ttm) Zacks Investment Research Thu, 07 May 2026 21:49:13 GMT
• vivek ramaswamy wins ohio primary for governor by wide margin News India Times Tue, 05 May 2026 07:00:00 GMT
• mucolipidosis ii market analysis: major segments, strategic developments, and leading companies openPR.com Mon, 04 May 2026 07:00:00 GMT
• lifesci advisors adds tricia truehart as managing director to expand investor relations platform citybiz Thu, 30 Apr 2026 07:00:00 GMT
• lifesci advisors expands team with appointment of tricia truehart in investor relations The Manila Times Thu, 30 Apr 2026 07:00:00 GMT
• parkinson's disease psychosis market size in the 7mm was ~usd 665 openPR.com Mon, 27 Apr 2026 07:00:00 GMT
• new cco and board role strengthen neurogene (nasdaq: ngne) leadership Stock Titan Mon, 20 Apr 2026 07:00:00 GMT
• leading companies fueling innovation and growth in the gm1 gangliosidosis market openPR.com Mon, 20 Apr 2026 07:00:00 GMT
• aav vectors in gene therapy clinical trial pipeline accelerates openPR.com Thu, 02 Apr 2026 13:34:03 GMT
• aav vectors in gene therapy clinical trial pipeline accelerates as 180+ pharma companies rigorously develop drugs for market entry... Barchart Wed, 01 Apr 2026 07:00:00 GMT
• gene therapy shows signs of delayed progression in fatal neurodegenerative disease MSN Tue, 10 Mar 2026 02:09:38 GMT
• Gene Therapy Shows Signs of Delayed Progression in Fatal Neurodegenerative Disease MedPage Today Wed, 11 Feb 2026 08:00:00 GMT
• gene therapy shows signs of delayed progression in fatal neurodegenerative disease MedPage Today Tue, 10 Feb 2026 08:00:00 GMT
• AAV9 Gene Therapy in Type II GM1 Gangliosidosis — A Phase 1–2 Trial The New England Journal of Medicine Fri, 06 Feb 2026 08:00:00 GMT
• the week in pharma: action, reaction and insight - week to october 22, 2021 The Pharma Letter Thu, 08 Jan 2026 02:53:53 GMT
• tay-sachs disease market outlook 2025–2032: strong cagr of 6.4% with usd 4.08 billion valuation GlobeNewswire Wed, 03 Dec 2025 08:00:00 GMT
• adeno-associated virus (aav) vectors in gene therapy: clinical openPR.com Tue, 28 Oct 2025 07:00:00 GMT
• sandhoff disease treatment market size projects usd 456.42 million by 2034 India Shorts Fri, 17 Oct 2025 07:00:00 GMT
• tay-sachs disease market analysis: trends, demand, size, and key player forecast 2032 |intrabio inc, recursion pharmaceuticals, in... industrytoday.co.uk Tue, 07 Oct 2025 08:48:36 GMT
• adeno-associated virus (aav) vectors in gene therapy pipeline openPR.com Mon, 29 Sep 2025 07:00:00 GMT
• gm1 gangliosidosis market: epidemiology, therapies, companies – delveinsight | featuring passage bio inc., gain therapeutics, sio ... The Globe and Mail Thu, 25 Sep 2025 07:00:00 GMT
• Laura Shawver finds her next big bet; Sangamo CFO hands in resignation Endpoints News Fri, 19 Sep 2025 07:00:00 GMT
• imbria pharmaceuticals strengthens leadership with new board and key clinical appointments GlobeNewswire Tue, 16 Sep 2025 07:00:00 GMT
• sandhoff disease therapeutics market growth forecast: usd 20.1 billion by 2035, driven by advances in gene therapy, hospital infra... industrytoday.co.uk Thu, 11 Sep 2025 07:00:00 GMT
• friday night lights essential to american culture Roswell Daily Record Wed, 03 Sep 2025 07:00:00 GMT
• aav vectors in gene therapy pipeline outlook 2025: clinical trial studies, ema, pdma, fda approvals, moa, roa, nda, ind, and compa... Barchart.com Fri, 29 Aug 2025 07:00:00 GMT
• gm1 gangliosidosis market massive growth opportunity ahead openPR.com Mon, 18 Aug 2025 13:17:00 GMT
• gm2 gangliosidosis market outlook, trends, therapies and growth forecast openPR.com Mon, 18 Aug 2025 12:43:00 GMT
• gm1 gangliosidosis market industry analysis by size, share, openPR.com Wed, 13 Aug 2025 07:00:00 GMT
• global gm2 gangliosidosis clinical trials 2025: drug pipeline, openPR.com Wed, 13 Aug 2025 03:44:00 GMT
• gm1 gangliosidosis market size and global industry forecast 2034 openPR.com Tue, 12 Aug 2025 11:14:00 GMT
• aav for the hereditary retinal diseases clinical trial GlobeNewswire Tue, 05 Aug 2025 07:00:00 GMT
• aav vectors in gene therapy pipeline appears promising with 180+ leading biotech and pharma companies driving innovation in the th... Barchart.com Thu, 17 Jul 2025 07:00:00 GMT
• tract bio appoints chris galloway, m.d., as chief medical and development officer citybiz Tue, 15 Jul 2025 13:27:48 GMT
• gm2 gangliosidosis market set to advance through 2034, fueled openPR.com Tue, 24 Jun 2025 13:04:00 GMT
• gm2 gangliosidosis pipeline overview: 8+ innovative therapies openPR.com Tue, 10 Jun 2025 17:53:00 GMT
• INBRIJA Positioned for Stronger Market Penetration as Demand Grows for Inhaled Parkinson's Therapy| DelveInsight PR Newswire Thu, 29 May 2025 07:00:00 GMT
• gene and cell therapies targeting cns disorders market in 2025 openPR.com Thu, 22 May 2025 12:09:00 GMT
• dutch biotech gets $146m for late-stage trials in three metabolic disorders Endpoints News Tue, 13 May 2025 07:00:00 GMT
• Ramaswamy to speak during Greene County Republican Party event at Nutter Center The Xenia Gazette Sat, 26 Apr 2025 07:00:00 GMT
• xadago/equfina set to revolutionize parkinson's disease treatment landscape | delveinsight The Malaysian Reserve Wed, 23 Apr 2025 07:00:00 GMT
• XADAGO/EQUFINA Set to Revolutionize Parkinson's Disease Treatment Landscape | DelveInsight PR Newswire Tue, 22 Apr 2025 07:00:00 GMT
• verrica pharmaceuticals adds dr. gavin corcoran to board of directors MyChesCo Fri, 04 Apr 2025 01:00:00 GMT
• verrica pharmaceuticals adds dr. gavin corcoran to board of directors MyChesCo Thu, 03 Apr 2025 07:00:00 GMT
• verrica pharmaceuticals appoints new board member by investing.com Investing.com India Thu, 03 Apr 2025 07:00:00 GMT
• verrica pharmaceuticals appoints gavin corcoran, m.d. to its board of directors GlobeNewswire Thu, 03 Apr 2025 02:26:57 GMT
• verrica pharmaceuticals appoints gavin corcoran, m.d. to its board of directors citybiz Wed, 02 Apr 2025 07:00:00 GMT
• strategic move: verrica adds formation bio cdo to board amid ycanth success Stock Titan Wed, 02 Apr 2025 07:00:00 GMT
• verrica pharmaceuticals appoints new board member by investing.com Investing.com UK Wed, 02 Apr 2025 07:00:00 GMT
• verrica pharmaceuticals expands board with new director Investing.com Wed, 02 Apr 2025 07:00:00 GMT
• strategic partnership to advance gene therapies for rare diseases: key trend in the gm1 gangliosidosis glob... WhaTech Tue, 25 Mar 2025 07:09:33 GMT
• how vivek ramaswamy got rich before going into politics Cincinnati Enquirer Mon, 24 Feb 2025 08:00:00 GMT
• how vivek ramaswamy got rich before going into politics Cincinnati Enquirer Sun, 23 Feb 2025 08:00:00 GMT
• Readying for Gubernatorial race, Indian American Ramaswamy lays out plan for Ohio News India Times Mon, 17 Feb 2025 08:00:00 GMT
• Alpha-Synuclein Inhibitors Clinical Trial Pipeline as Novel GlobeNewswire Thu, 13 Feb 2025 08:00:00 GMT
• quantifying hope: an eu perspective of rare disease therapeutic space and market dynamics Frontiers Sun, 02 Feb 2025 08:00:00 GMT
• week ahead in pharma (may 10- 14): fda decision, data readouts (rckt, avro, flxn, rare, hrtx…) RTTNews Tue, 28 Jan 2025 14:19:27 GMT
• week ahead in pharma (may 10- 14): fda decision, data readouts (rckt, avro, flxn, rare, hrtx…) RTTNews Mon, 27 Jan 2025 08:00:00 GMT
• biotech firm roivant sciences to go public via $7.3 billion spac deal pe-insights.com Sun, 26 Jan 2025 11:37:01 GMT
• Quantifying hope: an EU perspective of rare disease therapeutic space and market dynamics Frontiers Wed, 15 Jan 2025 04:55:32 GMT
• adeno-associated virus (aav) vectors in gene therapy pipeline openPR Mon, 30 Dec 2024 08:00:00 GMT
• amgen to buy horizon for $28b; merck, moderna tout cancer vaccine; fda approves second kras drug; and more Endpoints News Thu, 19 Dec 2024 08:00:00 GMT
• 3 biotech stocks with promising gene therapies to watch out in 2025 Nasdaq Tue, 17 Dec 2024 08:00:00 GMT
• parkinson's disease psychosis treatment market 2034: clinical openPR Wed, 11 Dec 2024 08:00:00 GMT
• adeno-associated virus (aav) vectors in gene therapy clinical openPR Thu, 05 Dec 2024 08:00:00 GMT
• sandhoff disease therapeutics market size, share, growth, openPR.com Wed, 13 Nov 2024 08:00:00 GMT
• 18-year-old vivek ramaswamy's powerful commencement address goes viral | watch Mathrubhumi English Wed, 13 Nov 2024 08:00:00 GMT
• mucolipidosis ii market report 2024-2033 - trends, size, growth & analysis openPR Wed, 30 Oct 2024 07:00:00 GMT
• a review of temporal interference, nanoparticles, ultrasound, gene therapy, and designer receptors for parkinson disease Nature Wed, 23 Oct 2024 07:00:00 GMT
• suppliers pushing novel analytical methods testing forward BioProcess Online Thu, 17 Oct 2024 07:00:00 GMT
• sandhoff disease therapeutics market: what represents the key openPR Tue, 08 Oct 2024 07:00:00 GMT
• gene and cell therapies for cns disorders market to experience openPR Fri, 04 Oct 2024 07:00:00 GMT
• adeno-associated virus (aav) vectors in gene therapy pipeline insights, clinical trials, treatment drugs, and companies 2024 Barchart.com Mon, 23 Sep 2024 07:00:00 GMT
• an updated snapshot of gene therapy clinical trials worldwide The American Journal of Managed Care® (AJMC®) Fri, 23 Aug 2024 07:00:00 GMT
• adeno-associated virus (aav) vectors in gene therapy pipeline 2024: clinical trials, fda, ema, and pmda approvals openPR Thu, 22 Aug 2024 07:00:00 GMT
• vivek ramaswamy net worth: a billionaire president candidate? CAknowledge.org Thu, 15 Aug 2024 01:13:16 GMT
• gm1 gangliosidosis treatment market growing rapidly by 2031 - openPR Mon, 15 Jul 2024 07:39:00 GMT
• Analyzing the biotech and pharma layoffs in 2024 drugdiscoverytrends.com Sat, 13 Jul 2024 07:00:00 GMT
• adeno-associated virus (aav) vectors in gene therapy pipeline 2024: clinical trials, fda, ema, and pmda EIN News Mon, 01 Jul 2024 11:48:00 GMT
• sio gene therapies | biotechnology | the pharmaletter The Pharma Letter Mon, 01 Jul 2024 02:07:26 GMT
• gene and cell therapies targeting cns disorders market to register incremental growth from (2024-2034) | EIN News Thu, 06 Jun 2024 18:28:00 GMT
• adeno-associated virus (aav) vectors in gene therapy pipeline outlook report 2024 (updated) openPR Thu, 06 Jun 2024 00:06:00 GMT
• sandhoff disease therapeutics market size analysis: 2023-2033 Future Market Insights Tue, 04 Jun 2024 02:57:07 GMT
• parkinson's disease clinical trials analysis 2024: ema, pdma, openPR.com Mon, 03 Jun 2024 07:00:00 GMT
• adeno-associated virus (aav) vectors in gene therapy pipeline analysis, 2024 openPR Fri, 31 May 2024 07:00:00 GMT
• closing bell: s split corp pref a flat on friday (sbn-pr-a) The Globe and Mail Thu, 30 May 2024 04:59:54 GMT
• closing bell: bristol gate concentrated cdn eqty etf flat on friday (bgc) The Globe and Mail Thu, 30 May 2024 03:06:10 GMT
• gene and cell therapies targeting cns disorders market deep analysis report 2024-2031 InsightAce Analytic Thu, 23 May 2024 07:00:00 GMT
• sio gene therapies announces prioritization of lead gene therapy programs in gm1 and gm2 gangliosidosis ... Barchart Sat, 18 May 2024 09:20:15 GMT
• why is squarespace (sqsp) stock rocketing higher today The Globe and Mail Mon, 13 May 2024 07:00:00 GMT
• are options traders betting on a big move in sio gene therapies (siox) stock? Yahoo New Zealand News Sat, 11 May 2024 13:29:35 GMT
• we think sio gene therapies (nasdaq:siox) needs to drive business growth carefully Yahoo Movies UK Mon, 06 May 2024 23:06:18 GMT
• adeno-associated virus (aav) vectors in gene therapy pipeline, clinical trials, fda approvals, and companies 2024 (updated) Barchart.com Mon, 06 May 2024 07:00:00 GMT
• with bristol myers’ latest cuts, biopharma layoffs reach 7,800+ BioWorld MedTech Thu, 25 Apr 2024 07:00:00 GMT
• how many sio gene therapies inc. (nasdaq:siox) shares do institutions own? Yahoo Movies Canada Fri, 12 Apr 2024 18:06:38 GMT
• illumina cfo to depart; jude samulski ends his run as askbio’s cso Endpoints News Fri, 12 Apr 2024 07:00:00 GMT
• global sandhoff disease therapeutics market to witness notable expansion, forecasted to reach us$ 17.91 million ... Market Research Blog Thu, 11 Apr 2024 07:00:00 GMT
• pharvaris appoints david nassif, j.d., as chief financial officer Afternoon Headlines Wed, 10 Apr 2024 19:38:00 GMT
• this boy struggled to walk before gene therapy. now, such treatments are poised to explode. Upworthy Sat, 06 Apr 2024 07:00:00 GMT
• quite a few insiders invested in sio gene therapies inc. (nasdaq:siox) last year which is positive news for ... Yahoo Movies UK Thu, 04 Apr 2024 16:36:06 GMT
• gm2 gangliosidosis pipeline assessment 2024 | clinical trials, openPR Tue, 02 Apr 2024 08:45:00 GMT
• cip merchant capital (lon:cip) trading 25% higher - american banking and market news American Banking and Market News Fri, 15 Mar 2024 08:00:04 GMT
• stocknews.com initiates coverage on genocea biosciences (nasdaq:gnca) American Banking News Fri, 15 Mar 2024 07:57:15 GMT
• sio gene therapies (nasdaq:siox) shares up 1.7% - american banking and market news AmericanBankingNEWS Fri, 15 Mar 2024 07:16:57 GMT
• diamondpeak (otcmkts:dphcu) stock price down 13.7% American Banking News Fri, 15 Mar 2024 07:11:55 GMT
Sio Gene Therapies, Inc(NASDAQ:SIOX) 
Sio Gene Therapies, Inc., a clinical-stage gene therapy company, focuses on developing various product candidates for debilitating neurodegenerative diseases. The company's clinical-stage programs include AXO-Lenti-PD program for the treatment of Parkinson's disease; AXO-AAV-GM1 program for the trea...
Website: http://www.axovant.com/
Founded: 2014
Full Time Employees: 38
CEO: Pavan Cheruvu
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends